FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq:GILD) announced today its results of operations for the quarter ended September 30, 2007. Total revenues for the third quarter of 2007 were $1.06 billion, up 41 percent compared to total revenues of $748.7 million for the third quarter of 2006. Net income for the third quarter of 2007 was $398.3 million, or $0.42 per diluted share, including after-tax stock-based compensation expense of $31.8 million. Excluding after-tax stock-based compensation expense, non-GAAP net income for the third quarter of 2007 was $430.1 million, or $0.45 per diluted share, compared to non-GAAP net income of $329.0 million, or $0.34 per diluted share, for the third quarter of 2006, which excluded after-tax stock-based compensation expense of $25.6 million and purchased in-process research and development (IPR&D) of $355.6 million.
